Impact of Hibiscus sabdariffa supplementation on human health: a narrative review
DOI:
https://doi.org/10.12775/JEHS.2026.89.70362Keywords
Hibiscus sabdariffa, supplementation, natural product, phytopharmacology, herbal medicine, antioxidant, anticancerAbstract
Background. Hibiscus sabdariffa has been used for millennia in various medical traditions worldwide to treat a variety of illnesses. Due to this fact, scientists have analysed its potential medical properties, especially in most common diseases globally, such as hypertension, diabetes, or cancer, looking for a medicine that is effective, widely available, and inexpensive.
Aim. The aim of this review is to summarize the current knowledge about Hibiscus sabdariffa supplementation on human health, with emphasis on the most common civilization diseases.
Materials and methods. A narrative review of available literature in English language was conducted using PubMed, Scopus, and Google Scholar databases. Emphasis was placed on experimental studies, with clinical, placebo-controlled experiments prioritized.
Conclusions. Hibiscus sabdariffa was found to have a positive impact on hypertension, hypercholesterolemia, obesity, renal and hepatic diseases. Moreover, the active compounds have anti-cancer properties, that could potentially help in developing new anti-cancer drugs in the future.
References
[1] I. Com, “Global traditional medicine strategy,” 2025, Accessed: Mar. 16, 2026. [Online]. Available: https://iris.who.int/.
[2] A. Amos and B. Khiatah, “Mechanisms of Action of Nutritionally Rich Hibiscus sabdariffa’s Therapeutic Uses in Major Common Chronic Diseases: A Literature Review,” Journal of the American Nutrition Association, vol. 41, no. 1, pp. 116–124, Jan. 2022, doi: 10.1080/07315724.2020.1848662.
[3] I. Da-Costa-Rocha, B. Bonnlaender, H. Sievers, I. Pischel, and M. Heinrich, “Hibiscus sabdariffa L. – A phytochemical and pharmacological review,” Food Chem., vol. 165, pp. 424–443, Dec. 2014, doi: 10.1016/j.foodchem.2014.05.002.
[4] B. H. Ali, N. Al Wabel, and G. Blunden, “Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.: a review,” Phytotherapy Research, vol. 19, no. 5, pp. 369–375, May 2005, doi: 10.1002/PTR.1628.
[5] C. C. Chen et al., “Hibiscus sabdariffa Extract Inhibits the Development of Atherosclerosis in Cholesterol-Fed Rabbits,” J. Agric. Food Chem., vol. 51, no. 18, pp. 5472–5477, Aug. 2003, doi: 10.1021/JF030065W.
[6] A. E. Alharbi, A. M. AlHussaini, and I. Alshami, “A Comprehensive Review of the Antimicrobial Effects of Hibiscus Species,” Cureus, vol. 16, no. 11, p. e73062, Nov. 2024, doi: 10.7759/CUREUS.73062.
[7] T. Koley, J. Majumder, M. Mahanta, T. K. Chowdhuri, and S. Gantait, “Characterization and diversity assessment of Hibiscus germplasms using morphological, biochemical and molecular markers,” South African Journal of Botany, vol. 169, pp. 164–177, Jun. 2024, doi: 10.1016/J.SAJB.2024.04.019.
[8] Mahadevan, N. & Shivali, & Kamboj, P.. (2009). Hibiscus sabdariffa Linn.-An overview. Natural Product Radiance. 8. 77-83.
[9] I. Da-Costa-Rocha, B. Bonnlaender, H. Sievers, I. Pischel, and M. Heinrich, “Hibiscus sabdariffa L. – A phytochemical and pharmacological review,” Food Chem., vol. 165, pp. 424–443, Dec. 2014, doi: 10.1016/J.FOODCHEM.2014.05.002.
[10] J. F. Morton, “Fruits of warm climates.,” 1987.
[11] A. Y. . Leung, Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. Wiley, 1980.
[12] A. Alberts, E. T. Moldoveanu, A. G. Niculescu, and A. M. Grumezescu, “Vitamin C: A Comprehensive Review of Its Role in Health, Disease Prevention, and Therapeutic Potential,” Molecules, vol. 30, no. 3, p. 748, Feb. 2025, doi: 10.3390/MOLECULES30030748.
[13] P. U. Rao, “Nutrient composition and biological evaluation of mesta (Hibiscus sabdariffa) seeds,” Plant Foods Hum. Nutr., vol. 49, no. 1, pp. 27–34, 1996, doi: 10.1007/BF01092519.
[14] A. Amos and B. Khiatah, “Mechanisms of Action of Nutritionally Rich Hibiscus sabdariffa’s Therapeutic Uses in Major Common Chronic Diseases: A Literature Review,” Journal of the American Nutrition Association, vol. 41, no. 1, pp. 116–124, Jan. 2022, doi: 10.1080/07315724.2020.1848662.
[15] B. H. Ali, N. Al Wabel, and G. Blunden, “Phytochemical, pharmacological and toxicological aspects ofHibiscus sabdariffa L.: a review,” Phytotherapy Research, vol. 19, no. 5, pp. 369–375, May 2005, doi: 10.1002/ptr.1628.
[16] Y. B. Laskar and P. B. Mazumder, “Insight into the molecular evidence supporting the remarkable chemotherapeutic potential of Hibiscus sabdariffa L.,” Biomedicine & Pharmacotherapy, vol. 127, p. 110153, Jul. 2020, doi: 10.1016/J.BIOPHA.2020.110153.
[17] A. N. Panche, A. D. Diwan, and S. R. Chandra, “Flavonoids: an overview,” J. Nutr. Sci., vol. 5, p. e47, Jan. 2016, doi: 10.1017/JNS.2016.41.
[18] A. Piovesana, E. Rodrigues, and C. P. Z. Noreña, “Composition analysis of carotenoids and phenolic compounds and antioxidant activity from hibiscus calyces ( Hibiscus sabdariffa L.) by HPLC‐DAD‐MS/MS,” Phytochemical Analysis, vol. 30, no. 2, pp. 208–217, Mar. 2019, doi: 10.1002/pca.2806.
[19] A. Piovesana and C. P. Z. Noreña, “Study of Acidified Aqueous Extraction of Phenolic Compounds from Hibiscus sabdariffa L. calyces,” The Open Food Science Journal, vol. 11, no. 1, pp. 25–34, Feb. 2019, doi: 10.2174/1874256401911010025.
[20] H. A. Sindi, L. J. Marshall, and M. R. A. Morgan, “Comparative chemical and biochemical analysis of extracts of Hibiscus sabdariffa,” Food Chem., vol. 164, pp. 23–29, Dec. 2014, doi: 10.1016/J.FOODCHEM.2014.04.097.
[21] Z. A. Khan et al., “Antioxidant and antibacterial activities of Hibiscus Rosa-sinensis Linn flower extracts.,” Pak. J. Pharm. Sci., vol. 27, no. 3, pp. 469–74, May 2014.
[22] P. C. M. Obiefuna, O. A. Owolabi, B. J. Adegunloye, I. P. Obiefuna, and O. A. Sofola, “The Petal Extract of Hibiscus sabdariffa Produces Relaxation of Isolated Rat Aorta,” International Journal of Pharmacognosy, vol. 32, no. 1, pp. 69–74, Jan. 1994, doi: 10.3109/13880209409082975.
[23] M. Sarr et al., “In vitro vasorelaxation mechanisms of bioactive compounds extracted from Hibiscus sabdariffa on rat thoracic aorta,” Nutr. Metab. (Lond)., vol. 6, no. 1, p. 45, 2009, doi: 10.1186/1743-7075-6-45.
[24] D. Ojeda, E. Jiménez-Ferrer, A. Zamilpa, A. Herrera-Arellano, J. Tortoriello, and L. Alvarez, “Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa,” J. Ethnopharmacol., vol. 127, no. 1, pp. 7–10, Jan. 2010, doi: 10.1016/J.JEP.2009.09.059.
[25] B. J. Adegunloye, J. O. Omoniyi, O. A. Owolabi, O. P. Ajagbonna, O. A. Sofola, and H. A. Coker, “Mechanisms of the blood pressure lowering effect of the calyx extract of Hibiscus sabdariffa in rats.,” Afr. J. Med. Med. Sci., vol. 25, no. 3, pp. 235–8, Sep. 1996.
[26] E. Jiménez-Ferrer et al., “Diuretic effect of compounds from Hibiscus sabdariffa by modulation of the aldosterone activity,” Planta Med., vol. 78, no. 18, pp. 1893–1898, 2012, doi: 10.1055/S-0032-1327864.
[27] A. Herrera-Arellano et al., “Clinical Effects Produced by a Standardized Herbal Medicinal Product of Hibiscus sabdariffa on Patients with Hypertension. A Randomized, Double-blind, Lisinopril-Controlled Clinical Trial,” Planta Med., vol. 73, no. 01, pp. 6–12, Jan. 2007, doi: 10.1055/S-2006-957065.
[28] D. C. Nwachukwu, E. Aneke, N. Z. Nwachukwu, L. F. O. Obika, U. I. Nwagha, and A. A. Eze, “Effect of Hibiscus sabdariffaon blood pressure and electrolyte profile of mild to moderate hypertensive Nigerians: A comparative study with hydrochlorothiazide,” Niger. J. Clin. Pract., vol. 18, no. 6, pp. 762–770, Nov. 2015, doi: 10.4103/1119-3077.163278.
[29] A.-R. Soleimani, H. Akbari, S. Soleimani, S. S. Beladi Mousavi, and M.-R. Tamadon, “Effect of sour tea (Lipicom) pill versus captopril on the treatment of hypertension.,” J. Renal Inj. Prev., vol. 4, no. 3, pp. 73–9, Sep. 2015, doi: 10.12861/jrip.2015.15.
[30] A. Herrera-Arellano, S. Flores-Romero, M. A. Chávez-Soto, and J. Tortoriello, “Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial,” Phytomedicine, vol. 11, no. 5, pp. 375–382, Jul. 2004, doi: 10.1016/J.PHYMED.2004.04.001.
[31] D. L. McKay, C. Y. O. Chen, E. Saltzman, and J. B. Blumberg, “Hibiscus Sabdariffa L. Tea (Tisane) Lowers Blood Pressure in Prehypertensive and Mildly Hypertensive Adults, , ,” J. Nutr., vol. 140, no. 2, pp. 298–303, Feb. 2010, doi: 10.3945/JN.109.115097.
[32] M. Jalalyazdi, J. Ramezani, A. Izadi-Moud, F. Madani-Sani, S. Shahlaei, and S. Ghiasi, “Effect of hibiscus sabdariffa on blood pressure in patients with stage 1 hypertension,” J. Adv. Pharm. Technol. Res., vol. 10, no. 3, pp. 107–111, Jul. 2019, doi: 10.4103/JAPTR.JAPTR_402_18.
[33] A. Bourqui et al., “Hypertension treatment with Combretum micranthum or Hibiscus sabdariffa, as decoction or tablet: a randomized clinical trial,” Journal of Human Hypertension 2020 35:9, vol. 35, no. 9, pp. 800–808, Sep. 2020, doi: 10.1038/s41371-020-00415-1.
[34] M. Al‐anbaki et al., “Hibiscus sabdariffa, a Treatment for Uncontrolled Hypertension. Pilot Comparative Intervention,” Plants 2021, Vol. 10, vol. 10, no. 5, May 2021, doi: 10.3390/PLANTS10051018.
[35] H. Mozaffari-Khosravi, Z. Ahadi, and K. Barzegar, “The Effect of Green Tea and Sour Tea on Blood Pressure of Patients with Type 2 Diabetes: A Randomized Clinical Trial,” J. Diet. Suppl., vol. 10, no. 2, pp. 105–115, Jun. 2013, doi: 10.3109/19390211.2013.790333.
[36] C. C. Chen et al., “Hibiscus sabdariffa Extract Inhibits the Development of Atherosclerosis in Cholesterol-Fed Rabbits,” J. Agric. Food Chem., vol. 51, no. 18, pp. 5472–5477, Aug. 2003, doi: 10.1021/JF030065W.
[37] J. F. B. da Costa et al., “Supplementation Effects of Hibiscus sabdariffa L. Flower Aqueous Extract on Body Composition and Metabolism in Eutrophic and Obese Rats,” Obesities 2025, Vol. 5, vol. 5, no. 4, Sep. 2025, doi: 10.3390/OBESITIES5040067.
[38] S. Gosain et al., “Hypolipidemic effect of ethanolic extract from the leaves of Hibiscus sabdariffa L. in hyperlipidemic rats.,” Acta Pol. Pharm., vol. 67, no. 2, pp. 179–84, 2010.
[39] O. Carvajal-Zarrabal et al., “The consumption of Hibiscus sabdariffa dried calyx ethanolic extract reduced lipid profile in rats,” Plant Foods for Human Nutrition, vol. 60, no. 4, pp. 153–159, Dec. 2005, doi: 10.1007/S11130-005-9023-X/METRICS.
[40] M. Kafeshani et al., “A comparative study of the effect of green tea and sour tea on blood pressure and lipid profile in healthy adult men,” ARYA Atheroscler., vol. 13, no. 3, p. 109, 2017, Accessed: Mar. 24, 2026. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC5677327/
[41] T. L. Lin, H. H. Lin, C. C. Chen, M. C. Lin, M. C. Chou, and C. J. Wang, “Hibiscus sabdariffa extract reduces serum cholesterol in men and women,” ., vol. 27, no. 3, pp. 140–145, Mar. 2007, doi: 10.1016/J.NUTRES.2007.01.007.
[42] A. Mohagheghi, S. Maghsoud, P. Khashayar, and M. Ghazi-Khansari, “The Effect of Hibiscus Sabdariffa on Lipid Profile, Creatinine, and Serum Electrolytes: A Randomized Clinical Trial,” ISRN Gastroenterol., vol. 2011, pp. 1–4, Nov. 2011, doi: 10.5402/2011/976019.
[43] M. Hajifaraji et al., “Effects of aqueous extracts of dried calyx of sour tea (Hibiscus sabdariffa L.) on polygenic dyslipidemia: A randomized clinical trial,” Avicenna J. Phytomed., vol. 8, no. 1, p. 24, 2018, Accessed: Mar. 24, 2026. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC5787994/
[44] C. M. Gurrola-Díaz, P. M. García-López, S. Sánchez-Enríquez, R. Troyo-Sanromán, I. Andrade-González, and J. F. Gómez-Leyva, “Effects of Hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (MeSy),” Phytomedicine, vol. 17, no. 7, pp. 500–505, Jun. 2010, doi: 10.1016/J.PHYMED.2009.10.014.
[45] S. Asgary, R. Soltani, M. Zolghadr, M. Keshvari, and N. Sarrafzadegan, “Evaluation of the effects of roselle (Hibiscus sabdariffa L.) on oxidative stress and serum levels of lipids, insulin and hs-CRP in adult patients with metabolic syndrome: a double-blind placebo-controlled clinical trial,” J. Complement. Integr. Med., vol. 13, no. 2, pp. 175–180, Jun. 2016, doi: 10.1515/JCIM-2015-0030.
[46] H. Mozaffari-Khosravi, B.-A. Jalali-Khanabadi, M. Afkhami-Ardekani, and F. Fatehi, “Effects of Sour Tea ( Hibiscus sabdariffa ) on Lipid Profile and Lipoproteins in Patients with Type II Diabetes,” The Journal of Alternative and Complementary Medicine, vol. 15, no. 8, pp. 899–903, Aug. 2009, doi: 10.1089/acm.2008.0540.
[47] F. Izadi, A. Farrokhzad, B. Tamizifar, M. J. Tarrahi, and M. H. Entezari, “Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial,” Phytother. Res., vol. 35, no. 1, pp. 477–485, Jan. 2021, doi: 10.1002/PTR.6826.
[48] K. Venkatesan, S. Venkatesan, and N. Manivannan, “Antibacterial Activity of Hibiscus sabdariffa (Rosella) Using Methanolic Extract,” J. Pharm. Bioallied Sci., vol. 16, no. Suppl 2, p. S1191, Apr. 2024, doi: 10.4103/JPBS.JPBS_527_23.
[49] R. Mohamed-Salem, C. R. Fernandez, E. Nieto-Pelegrin, B. Conde-Valentin, A. Rumbero, and N. Martinez-Quiles, “Aqueous extract of Hibiscus sabdariffa inhibits pedestal induction by enteropathogenic E. coli and promotes bacterial filamentation in vitro,” PLoS One, vol. 14, no. 3, p. e0213580, Mar. 2019, doi: 10.1371/JOURNAL.PONE.0213580.
[50] M. Fullerton, J. Khatiwada, J. U. Johnson, S. Davis, and L. L. Williams, “Determination of Antimicrobial Activity of Sorrel ( Hibiscus sabdariffa ) on Esherichia coli O157:H7 Isolated from Food, Veterinary, and Clinical Samples,” J. Med. Food, vol. 14, no. 9, pp. 950–956, Sep. 2011, doi: 10.1089/jmf.2010.0200.
[51] M. Tolulope, “Cytotoxicity and antibacterial activity of Methanolic extract of Hibiscus sabdariffa,” Journal of Medicinal Plants Research, vol. 1, no. 1, pp. 9–013, 2007, Accessed: Mar. 25, 2026. [Online]. Available: http://www.academicjournals.org/JMPR
[52] A. A. Abass et al., “Antimicrobial effect of Red Roselle (Hibiscus Sabdariffa) against different types of oral bacteria,” J. Med. Life, vol. 15, no. 1, p. 89, 2022, doi: 10.25122/JML-2021-0184.
[53] K. Takada et al., “Medicinal herbs, especially Hibiscus sabdariffa, inhibit oral pathogenic bacteria,” J. Oral Biosci., vol. 66, no. 1, pp. 179–187, Mar. 2024, doi: 10.1016/J.JOB.2024.01.006.
[54] W. H. Liu, C. C. Hsu, and M. C. Yin, “In vitro anti-Helicobacter pylori activity of diallyl sulphides and protocatechuic acid,” Phytother. Res., vol. 22, no. 1, pp. 53–57, Jan. 2008, doi: 10.1002/PTR.2259.
[55] S. T. S. Hassan, K. Berchová, M. Majerová, M. Pokorná, and E. Švajdlenka, “In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates,” Pharm. Biol., vol. 54, no. 9, pp. 1736–1740, Sep. 2016, doi: 10.3109/13880209.2015.1126618.
[56] I. Alshami and A. E. Alharbi, “Hibiscus sabdariffa extract inhibits in vitro biofilm formation capacity of Candida albicans isolated from recurrent urinary tract infections,” Asian Pac. J. Trop. Biomed., vol. 4, no. 2, p. 104, 2014, doi: 10.1016/S2221-1691(14)60217-3.
[57] Y. C. Chang, H. P. Huang, J. D. Hsu, S. F. Yang, and C. J. Wang, “Hibiscus anthocyanins rich extract-induced apoptotic cell death in human promyelocytic leukemia cells,” Toxicol. Appl. Pharmacol., vol. 205, no. 3, pp. 201–212, Jun. 2005, doi: 10.1016/J.TAAP.2004.10.014.
[58] A. Malacrida, D. Maggioni, A. Cassetti, G. Nicolini, G. Cavaletti, and M. Miloso, “Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells,” Nutr. Cancer, vol. 68, no. 7, pp. 1161–1170, Oct. 2016, doi: 10.1080/01635581.2016.1208830.
[59] C. Chiu, S. Hsuan, H. Lin, C. Hsu, F. Chou, and J. Chen, “Hibiscus sabdariffa Leaf Polyphenolic Extract Induces Human Melanoma Cell Death, Apoptosis, and Autophagy,” J. Food Sci., vol. 80, no. 3, Mar. 2015, doi: 10.1111/1750-3841.12790.
[60] H.-H. Lin, J.-H. Chen, W.-H. Kuo, and C.-J. Wang, “Chemopreventive properties of Hibiscus sabdariffa L. on human gastric carcinoma cells through apoptosis induction and JNK/p38 MAPK signaling activation,” Chem. Biol. Interact., vol. 165, no. 1, pp. 59–75, Jan. 2007, doi: 10.1016/j.cbi.2006.10.011.
[61] H. Lin, H. Huang, C. Huang, J. Chen, and C. Wang, “Hibiscus polyphenol‐rich extract induces apoptosis in human gastric carcinoma cells via p53 phosphorylation and p38 MAPK/FasL cascade pathway,” Mol. Carcinog., vol. 43, no. 2, pp. 86–99, Jun. 2005, doi: 10.1002/mc.20103.
[62] T. Yeasmin et al., “Growth Inhibition and Apoptosis of Ehrlich Ascites Carcinoma Cells by Methanol Extract from the Calyx of Hibiscus Sabdariffa Linn,” Central Asian Journal of Medical Sciences, vol. 4, no. 2, pp. 155–165, Jun. 2018, doi: 10.24079/cajms.2018.06.007.
[63] D. X. Hou, X. Tong, N. Terahara, D. Luo, and M. Fujii, “Delphinidin 3-sambubioside, a Hibiscus anthocyanin, induces apoptosis in human leukemia cells through reactive oxygen species-mediated mitochondrial pathway,” Arch. Biochem. Biophys., vol. 440, no. 1, pp. 101–109, Aug. 2005, doi: 10.1016/J.ABB.2005.06.002.
[64] T. H. Tseng, T. W. Kao, C. Y. Chu, F. P. Chou, W. L. Lin, and C. J. Wang, “Induction of apoptosis by Hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression,” Biochem. Pharmacol., vol. 60, no. 3, pp. 307–315, Aug. 2000, doi: 10.1016/S0006-2952(00)00322-1.
[65] A. Malacrida et al., “Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells,” Biochem. Biophys. Rep., vol. 32, p. 101353, Dec. 2022, doi: 10.1016/J.BBREP.2022.101353.
[66] S. Khaghani et al., “Selective Cytotoxicity and Apoptogenic Activity of Hibiscus Sabdariffa Aqueous Extract Against MCF-7 Human Breast Cancer Cell Line,” J. Cancer Ther., vol. 2, no. 3, pp. 394–400, Aug. 2011, doi: 10.4236/JCT.2011.23054.
[67] Z. E. Millan et al., “Lyophilized Extract of Hibiscus sabdariffa L. Induces Cytotoxicity in Breast Cancer Cell Lines,” Proceedings 2020, Vol. 61, vol. 61, no. 1, p. 22, Oct. 2020, doi: 10.3390/IECN2020-07002.
[68] T. R. Bassong, L. V. Kenmogne, C. F. Awounfack, D. T. Ndinteh, D. Njamen, and S. Zingue, “Effects of Hibiscus sabdariffa Calyxes Aqueous Extract on Antioxidant Status and Histopathology in Mammary Tumor-Induced in Rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2022, no. 1, p. 9872788, Jan. 2022, doi: 10.1155/2022/9872788.
[69] Mossalam, Hala & Aty, Olfat & Morgan, Enas & Youssef, Sahar & Mackawy, Amal. (2011). Biochemical and Ultra Structure Studies of the Antioxidant Effect of Aqueous Extract of Hibiscus Sabdariffa on the Nephrotoxicity Induced by Organophosphorous Pesticide (Malathion) on the Adult Albino Rats. Life Science Journal. 8. 561-574.
[70] B. O. Ajiboye et al., “Nephroprotective Effect of Hibiscus Sabdariffa Leaf Flavonoid Extracts via KIM-1 and TGF-1β Signaling Pathways in Streptozotocin-Induced Rats,” ACS Omega, vol. 9, no. 17, p. 19334, Apr. 2024, doi: 10.1021/ACSOMEGA.4C00254.
[71] W. C. Lee et al., “Polyphenol extracts from Hibiscus sabdariffa Linnaeus attenuate nephropathy in experimental type 1 diabetes,” J. Agric. Food Chem., vol. 57, no. 6, pp. 2206–2210, Mar. 2009, doi: 10.1021/JF802993S.
[72] L. Manzano-Pech et al., “The Chronic Elevated Consumption of Hibiscus sabdariffa Linnaeus Results in Kidney Damage Associated with Excess H2S,” Int. J. Mol. Sci., vol. 27, no. 5, p. 2190, Feb. 2026, doi: 10.3390/ijms27052190.
[73] D. C. Nwachukwu, E. I. Aneke, N. Z. Nwachukwu, N. Azubike, and L. F. Obika, “Does consumption of an aqueous extract of Hibscus sabdariffa affect renal function in subjects with mild to moderate hypertension?,” The Journal of Physiological Sciences, vol. 67, no. 1, pp. 227–234, Jan. 2017, doi: 10.1007/S12576-016-0458-Z.
[74] V. Prasongwatana, S. Woottisin, P. Sriboonlue, and V. Kukongviriyapan, “Uricosuric effect of Roselle (Hibiscus sabdariffa) in normal and renal-stone former subjects,” J. Ethnopharmacol., vol. 117, no. 3, pp. 491–495, May 2008, doi: 10.1016/J.JEP.2008.02.036.
[75] S. Kirdpon, S. N. Nakorn, and W. Kirdpon, “Changes in urinary chemical composition in healthy volunteers after consuming roselle (Hibiscus sabdariffa Linn.) juice.,” J. Med. Assoc. Thai., vol. 77, no. 6, pp. 314–21, Jun. 1994.
[76] M. T. Olaleye and B. T. J. Rocha, “Acetaminophen-induced liver damage in mice: Effects of some medicinal plants on the oxidative defense system,” Experimental and Toxicologic Pathology, vol. 59, no. 5, pp. 319–327, Mar. 2008, doi: 10.1016/J.ETP.2007.10.003.
[77] B. H. Ali, H. M. Mousa, and S. El-Mougy, “The effect of a water extract and anthocyanins of Hibiscus sabdariffa L. on paracetamol-induced hepatoxicity in rats,” Phytotherapy Research, vol. 17, no. 1, pp. 56–59, Jan. 2003, doi: 10.1002/PTR.1084.
[78] S. O. Asagba, M. A. Adaikpoh, H. Kadiri, and F. O. Obi, “Influence of Aqueous Extract of Hibiscus sabdariffa L. Petal on Cadmium Toxicity in Rats,” Biol. Trace Elem. Res., vol. 115, no. 1, pp. 47–58, 2007, doi: 10.1385/BTER:115:1:47.
[79] J. Y. Liu, C. C. Chen, W. H. Wang, J. D. Hsu, M. Y. Yang, and C. J. Wang, “The protective effects of Hibiscus sabdariffa extract on CCl4-induced liver fibrosis in rats,” Food and Chemical Toxicology, vol. 44, no. 3, pp. 336–343, Mar. 2006, doi: 10.1016/J.FCT.2005.08.003.
[80] J. Prasomthong, N. Limpeanchob, S. Daodee, P. Chonpathompikunlert, and S. Tunsophon, “Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet,” Sci. Rep., vol. 12, no. 1, p. 7022, Dec. 2022, doi: 10.1038/S41598-022-11027-9.
[81] H.-C. Chang, C.-H. Peng, D.-M. Yeh, E.-S. Kao, and C.-J. Wang, “Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans,” Food Funct., vol. 5, no. 4, p. 734, 2014, doi: 10.1039/c3fo60495k.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Kacper Szada-Borzyszkowski, Konstancja Owczarenko, Bartosz Wróbel, Lena Wójcik, Michał Filipski, Krzysztof Gadzalski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 25
Number of citations: 0
